✦ LIBER ✦

An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): Data report from Italy

✍ Scribed by Tiseo, Marcello; Gridelli, Cesare; Cascinu, Stefano; Crinò, Lucio; Piantedosi, Franco Vito; Grossi, Francesco; Brandes, Alba A.; Labianca, Roberto; Siena, Salvatore; Amoroso, Domenico; Belvedere, Ornella; Valentino, Brunello; Bearz, Alessandra; Venturino, Paola; Ardizzoni, Andrea

Book ID: 119320019
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 541 KB
Volume: 64
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2008.09.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survival outcomes in patients with advan

Survival outcomes in patients with advanced non-small cell lung cancer treated with erlotinib: expanded access programme data from Belgium (the TRUST study)

✍ Van Meerbeeck, J.; Galdermans, D.; Bustin, F.; De Vos, L.; Lechat, I.; Abraham, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 551 KB

6608 POSTER An expanded access clinical

6608 POSTER An expanded access clinical program of erlotinib in patients (pts) with advanced stage IIIb/ IV non-small-cell lung cancer (NSCLC) – an update of a single institution experience

✍ Tewes, M.; Gauler, T.; Schuett, P.; Sailer, V.; Bildat, S.; Korfee, S.; Seeber, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

9151 Treatment of patients with advanced

9151 Treatment of patients with advanced non-small-cell lung cancer (NSCLC) with erlotinib: results from clinical practice

✍ Faehling, M.; Eckert, R.; Kuom, S.; Kamp, T.; Stoiber, K.; Kropf, C.; Rüdiger, S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Erlotinib treatment results in patients

Erlotinib treatment results in patients with advanced non-small-cell lung cancer (NSCLC)—Influence of clinical predictors

✍ Salajka, F.; Pešek, M.; Skřičková, J.; Zatloukal, P.; Koubková, L.; Grygárková, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Efficacy and safety of gefitinib in chem

Efficacy and safety of gefitinib in chemonaive patients with advanced non-small cell lung cancer treated in an Expanded Access Program

✍ Govindan, Ramaswamy; Natale, Ronald; Wade, James; Herbst, Roy; Krebs, Annetta; R 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

P-942 Iressa in patients with advanced n

P-942 Iressa in patients with advanced non-small cell lung cancer(NSCLC) progressed to chemotherapy. Spain expanded acces program (EAP)

✍ Castellano, D.; Neciosup, S.; Velasco, A.; Masutti, B.; Gomez, C.; Moyano, A.; C 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 152 KB